The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against using testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it has not been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study involved roughly 800 older men with low testosterone and symptoms related to this affliction, like http://tinyurl.com/guccrce
sexual and physical dysfunction. Since the heart health of the men was monitored, the research is expected
to shed more light on the safety of testosterone therapy.
The recent conflicting findings on testosterone treatment prompted his team to conduct a big systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among men and Patel. An estimated 13 million men in the USA have problems with low testosterone, which occurs when the body does not make enough hormones because of a difficulty with the testicles or pituitary gland. This explains apparent aging, somebody's unexpected weight gain and decline of energy.
And many girls have a knee-jerk feeling that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only doesn't raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser thinks this will probably remain the status quo for a little while, given the prohibitive cost of conducting the long-term safety studies needed to win completer FDA acceptance.